text_1: Pioglitazone use is not associated with an increased risk of prostate cancer.
text_2: The increased prostate and pancreatic cancer risks associated with ever use of pioglitazone merit further investigation to assess whether they are causal or are due to chance, residual confounding, or reverse causality.